Paper Review Records
全部论文审稿周期
24 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
296
天
Assessment of Pharmacokinetic Interaction and Clinical Efficacy of Clopidogrel Co‐administered with Ilaprazole
作者
Damodharan N; Priyadharshini A; Vijayakumar T M; Rajesh N A展开收起
作者单位
1. Department of Pharmaceutics SRM College of Pharmacy SRM Institute of Science and Technology Kattankulathur Tamil Nadu India; 2. Department of Pharmacy Practice SRM College of Pharmacy SRM Institute of Science and Technology Kattankulathur Tamil Nadu India; 3. Department of Medical Gastroenterology SRM Medical College Hospital and Research Centre SRM Institute of Science and Technology Kattankulathur Tamil Nadu India展开收起
103
天
Bioequivalence Study of Two Ibuprofen Arginine Formulations in Healthy Chinese Subjects Under Fed Conditions
作者
Yiyang Ying; Chunqi Huang; Li Xu; Yi Wu; Shufan Cai; Lijun Ye; Xiangxin Huang; Lin Wang; Ying Wang展开收起
作者单位
1. The First Clinical Medical College Zhejiang Chinese Medical University Hangzhou Zhejiang Province China; 2. Department of Laboratory Medicine The Second Affiliated Hospital of Zhejiang Chinese Medical University, Xinhua Hospital of Zhejiang Province Hangzhou Zhejiang China; 3. School of Pharmacy Hangzhou Normal University Hangzhou Zhejiang China; 4. Clinical Research Center Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University Hangzhou China; 5. Zhejiang Key Laboratory of Zero Magnetic Medicine Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University Hangzhou China展开收起
214
天
Exposure–Response Relationship of Dostarlimab in Primary Advanced/Recurrent Endometrial Cancer: Results From Interim Analysis 2 of Part 1 of the RUBY Trial
作者
Mita Kuchimanchi; Trine Lembrecht Jørgensen; Eva Hanze; Angela Jain; Oskar Alskär; Oleksandr Zub; Mark S. Shahin; Anthoula Koliadi; Bhavana Pothuri; Thomas Krivak; Mikalai Pishchyk; Yakir Segev; Floor J. Backes; Christine Gennigens; Sara Bouberhan; Stefan Zajic; Murad Melhem; Joseph Buscema展开收起
作者单位
1. GSK Waltham MA USA; 2. Department of Oncology Odense University Hospital Odense Denmark; 3. qPharmetra Uppsala Sweden; 4. Fox Chase Cancer Center Philadelphia PA USA; 5. Chernihiv Medical Center of Modern Oncology Chernihiv Regional Council Chernihiv Ukraine; 6. Division of Gynecologic Oncology Penn State Hershey Medical Center Hershey PA USA; 7. Department of Gynecologic Oncology Uppsala University Hospital Uppsala Sweden; 8. Nordic Society of Gynaecological Oncology (NSGO) Clinical Trial Unit Copenhagen Denmark; 9. Departments of Obstetrics and Gynecology and Medicine Division of Gynecologic Oncology NYU Langone Health New York NY USA; 10. GOG Foundation Philadelphia PA USA; 11. Division of Gynecologic Oncology The Western Pennsylvania Hospital Pittsburgh PA USA; 12. Grodno Regional Clinical Hospital Grodno Belarus; 13. Carmel Medical Center Technion‐Israel Institute of Technology Haifa Israel; 14. Division of Gynecologic Oncology Ohio State University Columbus OH USA; 15. Department of Medical Oncology CHU of Liège Liège Belgium; 16. Belgium and Luxembourg Gynaecological Oncology Group (BGOG) Leuven Belgium; 17. Massachusetts General Hospital Boston MA USA; 18. Affiliation at time of study GSK Collegeville PA USA; 19. TMC Healthcare Cancer Center Tucson AZ USA展开收起
88
天
Open‐Label, Balanced, Randomized, Single‐Dose, Three‐Treatment, Three‐Sequence, Three‐Period, Three‐Way Crossover Oral Bioequivalence Study of Desmopressin Acetate Oral Solution
作者
Adam Christensen; Axay Parth; Mansi Kotak; Danka Radosavjevic; Catherine Gorman Moore; Byung‐Woun Seo展开收起
作者单位
1. Eton Pharmaceuticals Deer Park IL USA; 2. Veeda Clinical Research, Mehsana Panchot India; 3. Veeda Clinical Research Ahmedabad Gujarat India展开收起
87
天
Safety, Tolerability, Pharmacokinetics, Food Effect of Ribitol, and Its Effect on QTcF in Healthy Adults: First‐in‐Human, Randomized, Double‐Blind (Sponsor Unblinded), Placebo‐Controlled Studies
作者
Daniel D. Gretler; Athiwat Hutchaleelaha; Uma Sinha; Kristen Rickert; Doug Sproule展开收起
作者单位
1. Bridgebio Pharma, Inc. Palo Alto CA USA展开收起
55
天
Phase 1 Study of Paltusotine, a Novel Oral Once‑Daily, Nonpeptide Selective Somatostatin Receptor 2 Agonist, in Healthy Japanese Adults
作者
Fumio Otsuka; Keiko Hanabara; Seigo Akari; Katsunori Kitamoto; Yosuke Inagaki; Dylan Glatt; Harumi Murakami; Naoki Uchida展开收起
作者单位
1. Department of General Medicine Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan; 2. Medical Affairs Group Medical Affairs Department Sanwa Kagaku Kenkyusho Co., Ltd. Nagoya Japan; 3. Project Management Group Project Management Department Sanwa Kagaku Kenkyusho Co., Ltd. Nagoya Japan; 4. Clinical Development Department Sanwa Kagaku Kenkyusho Co., Ltd. Nagoya Japan; 5. Crinetics Pharmaceuticals, Inc. San Diego USA; 6. Souseikai Sumida Hospital Tokyo Japan; 7. Division of Clinical Pharmacology Department of Pharmacology Showa Medical University School of Medicine Tokyo Japan展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天